Effect of atorvastatin in patients 65 years of age with type 2 diabetes: Subgroup analysis from the collaborative atorvastatin diabetes study (CARDS) by DeMicco, D, Luo, D, Betteridge, D, Colhoun, H, Durrington, P, Hitman, G, Neil, H, Livingstone, S, Fuller, J

Analysis of efficacy and safety in patients aged 65-75 years at randomization: Collaborative Atorvastatin Diabetes Study (CARDS). by Neil, H, DeMicco, D, Luo, D, Betteridge, D, Colhoun, H, Durrington, P, Livingstone, S, Fuller, J, Hitman, G

Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study (CARDS). by Colhoun, H, Betteridge, D, Durrington, P, Hitman, G, Neil, H, Livingstone, S, Charlton-Menys, V, DeMicco, D, Fuller, J

Change in Lp-PLA2 With Risk Change on Statin Therapy in the Collaborative Atorvastatin Diabetes Study (CARDS) by Betteridge, D, Colhoun, H, Durrington, P, Hitman, G, Neil, H, Livingstone, S, Bao, W, DeMicco, D, Preston, G, Fuller, J, Investigators, CARDS

Targets of statin therapy: LDL cholesterol, non-HDL cholesterol, and apolipoprotein B in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS). by Charlton-Menys, V, Betteridge, D, Colhoun, H, Fuller, J, France, M, Hitman, G, Livingstone, S, Neil, H, Newman, C, Szarek, M, DeMicco, D, Durrington, P

Apolipoproteins, cardiovascular risk and statin response in type 2 diabetes: the Collaborative Atorvastatin Diabetes Study (CARDS). by Charlton-Menys, V, Betteridge, D, Colhoun, H, Fuller, J, France, M, Hitman, G, Livingstone, S, Neil, H, Newman, C, Szarek, M, DeMicco, D, Durrington, P

C-reactive Protein and Amyloid A as Predictors of Cardiovascular Events in Type 2 Diabetes in CARDS by Charlton-Menys, V, Colhoun, H, Betteridge, D, Soedamah-Muthu, S, Hitman, G, Neil, H, Livingstone, S, Bao, W, DeMicco, D, Preston, G, Fuller, J, Durrington, P, Investigators, CARDS